Anti-ENTP1/ CD39/ ENTPD1 monoclonal antibody

Anti-ENTP1/ CD39/ ENTPD1 antibody for FACS & in-vivo assay

Target products collectionGo to CD39/ENTPD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T58298-Ab-1/ GM-Tg-hg-T58298-Ab-2Anti-Human CD39/ENTPD1 monoclonal antibodyHuman
GM-Tg-rg-T58298-Ab-1/ GM-Tg-rg-T58298-Ab-2Anti-Rat CD39/ENTPD1 monoclonal antibodyRat
GM-Tg-mg-T58298-Ab-1/ GM-Tg-mg-T58298-Ab-2Anti-Mouse CD39/ENTPD1 monoclonal antibodyMouse
GM-Tg-cynog-T58298-Ab-1/ GM-Tg-cynog-T58298-Ab-2Anti-Cynomolgus/ Rhesus macaque CD39/ENTPD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T58298-Ab-1/ GM-Tg-felg-T58298-Ab-2Anti-Feline CD39/ENTPD1 monoclonal antibodyFeline
GM-Tg-cang-T58298-Ab-1/ GM-Tg-cang-T58298-Ab-2Anti-Canine CD39/ENTPD1 monoclonal antibodyCanine
GM-Tg-bovg-T58298-Ab-1/ GM-Tg-bovg-T58298-Ab-2Anti-Bovine CD39/ENTPD1 monoclonal antibodyBovine
GM-Tg-equg-T58298-Ab-1/ GM-Tg-equg-T58298-Ab-2Anti-Equine CD39/ENTPD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T58298-Ab-1/ GM-Tg-hg-T58298-Ab-2; GM-Tg-rg-T58298-Ab-1/ GM-Tg-rg-T58298-Ab-2;
GM-Tg-mg-T58298-Ab-1/ GM-Tg-mg-T58298-Ab-2; GM-Tg-cynog-T58298-Ab-1/ GM-Tg-cynog-T58298-Ab-2;
GM-Tg-felg-T58298-Ab-1/ GM-Tg-felg-T58298-Ab-2; GM-Tg-cang-T58298-Ab-1/ GM-Tg-cang-T58298-Ab-2;
GM-Tg-bovg-T58298-Ab-1/ GM-Tg-bovg-T58298-Ab-2; GM-Tg-equg-T58298-Ab-1/ GM-Tg-equg-T58298-Ab-2
Products NameAnti-CD39/ENTPD1 monoclonal antibody
Formatmab
Target NameCD39
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CD39 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ENTP1/ CD39/ ENTPD1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLV000671human ENTPD1 Lentivirus plasmid
    ORF Viral VectorvGMLV000671human ENTPD1 Lentivirus particle


    Target information

    Target IDGM-T58298
    Target NameCD39
    Gene ID953,12495,64519,486810,101096356,282223,100070956
    Gene Symbol and Synonyms2610206B08Rik,ATPDase,CD39,E130009M23Rik,ENTPD1,NTPDase-1,SPG64
    Uniprot AccessionP49961,P97687,O18956
    Uniprot Entry NameENTP1_HUMAN,ENTP1_RAT,ENTP1_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseN/A
    Gene EnsemblENSG00000138185
    Target ClassificationCheckpoint-Immuno Oncology

    The target: CD39, gene name: ENTPD1, also named as ATPDase, CD39, NTPDase-1, SPG64. The protein encoded by this gene is a plasma membrane protein that hydrolyzes extracellular ATP and ADP to AMP. Inhibition of this protein's activity may confer anticancer benefits. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.